Luis E. Salazar Leon1,2,3
Roy V. Sillitoe1,2,3,4,5*- 1Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States
- 2Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States
- 3Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, United States
- 4Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States
- 5Development, Disease Models & Therapeutics Graduate Program, Baylor College of Medicine, Houston, TX, United States
Although dystonia is the third most common movement disorder, patients often also experience debilitating nonmotor defects including impaired sleep. The cerebellum is a central component of a “dystonia network” that plays various roles in sleep regulation. Importantly, the primary driver of sleep impairments in dystonia remains poorly understood. The cerebellum, along with other nodes in the motor circuit, could disrupt sleep. However, it is unclear how the cerebellum might alter sleep and mobility. To disentangle the impact of cerebellar dysfunction on motion and sleep, we generated two mouse genetic models of dystonia that have overlapping cerebellar circuit miswiring but show differing motor phenotype severity: Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice. In both models, excitatory climbing fiber to Purkinje cell neurotransmission is blocked, but only the Ptf1aCre;Vglut2fx/fx mice have severe twisting. Using in vivo ECoG and EMG recordings we found that both mutants spend greater time awake and in NREM sleep at the expense of REM sleep. The increase in awake time is driven by longer awake bouts rather than an increase in bout number. We also found a longer latency to reach REM in both mutants, which is similar to what is reported in human dystonia. We uncovered independent but parallel roles for cerebellar circuit dysfunction and motor defects in promoting sleep quality versus posture impairments in dystonia.
Introduction
Dystonia presents with phenotypic and etiologic heterogeneity. Considered the third most common movement disorder, “dystonia” does not comprise a single disease or symptom, but rather describes an array of disorders sharing overlapping behavioral outcomes. While different forms of dystonia express unique etiologies, substantial evidence implicates the cerebellum as a major node in the underlying network disruptions [1–4]. Dysfunction of Purkinje cells and the cerebellar nuclei, the primary outputs of the cerebellar cortex and cerebellum, respectively, are implicated in both hereditary and idiopathic forms of dystonia [4–7]. Importantly, while cerebellar dysfunction is sufficient to induce dystonia in animal models, therapies addressing cerebellar dysfunction can modulate dystonia and reduce motor symptom severity. One such therapy, cerebellar deep brain stimulation (DBS), has been used to effectively reduce motor symptom severity in both mouse models [4] and human patients [8, 9], further suggesting a critical cerebellar involvement in the etiology of dystonia. However, nonmotor behaviors are also relevant to the cerebellum and to dystonia.
Along with its known role in regulating motor function, increasing evidence shows that the cerebellum also serves as a key brain region in the control of a variety of nonmotor behaviors such as cognitive and emotional processing [10], associative learning [11], and reward expectation [11, 12]. Recent work also suggests that the cerebellum may play a role in sleep-related behaviors. Purkinje cells and cerebellar nuclei neurons have been found to display sleep-dependent activity, increasing their firing during NREM (non-rapid eye movement) sleep [13–16]. In addition, lesioning of the cerebellar vermis has been shown to impair sleep, suggesting that normal cerebellar circuitry and activity are important for maintaining sleep rhythms [17, 18]. Numerous studies have shown that cerebellar disruptions form the basis for the many comorbidities of motor disorders [19–22]. However, the role of the cerebellum and its circuit components in sleep regulation have not been studied thoroughly in dystonia. It is known that dystonic patients demonstrate increased sleep latency and REM (rapid eye movement) latency, and in some cases, persistent involuntary muscle contractions during sleep [23–25]. It is also noted that therapeutics which successfully alleviate the motor symptoms of dystonia appear to have little to no effect on the sleep disruptions [26]. The importance of addressing sleep dysfunction is becoming increasingly apparent in society, as sleep disruptions can significantly impact quality of life, driving many subsequent comorbidities [27, 28]. Disrupted sleep is also associated with impaired motor learning/function [29–31], as synaptic activity is normalized during sleep [32]. Together, the mounting evidence inspires a compelling model in which sleep and motor dysfunction in dystonia comprise two halves of a self-propelling cycle. It is possible that cerebellar dysfunction drives both the more commonly appreciated motor abnormalities and the nonmotor sleep disruptions, although how they emerge needs to be systematically resolved.
It remains unclear whether dystonic motor dysfunctions persist during all stages of sleep, and consistently across different manifestations of the disease; recent evidence from a survey of cervical dystonia patients suggests that, in cases of idiopathic cervical dystonia, it does [24]. The lack of clarity on which factors (motor dysfunction and/or cerebellar dysfunction) drive sleep dysfunction in dystonia highlights the significance of this knowledge gap. To investigate the relationship between cerebellar dysfunction, motor dysfunction, and sleep, here we used a constitutively active Cre/lox-p system to drive the deletion of the Vglut2 gene in afferent neurons that project excitatory fibers that ultimately communicate with the Purkinje cells. Vglut2 was deleted using the Ptf1a and Pdx1 gene regulatory elements to spatially drive Cre expression: the resulting mice had the genotypes Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx. The Ptf1a and Pdx1 genes are expressed in the excitatory neurons of the inferior olive, a region of the brainstem, which projects afferent fibers to the cerebellar cortex and terminate as excitatory climbing fibers [4, 33]. However, Ptf1a expression occurs in a wider distribution across the inferior olive relative to Pdx1, and Pdx1 is also expressed in mossy fiber afferent neurons (Lackey et al., 2023 in preparation). Therefore, the silencing of excitatory climbing fiber synapses occurs with differential coverage in mice with Ptf1a- versus Pdx1-driven Cre expression. Only Ptf1aCre;Vglut2fx/fx mice present with severe motor dysfunction involving twisting of the torso and hyperextensions of the back and limbs [4], while Pdx1Cre;Vglut2fx/fx adult mice show only subtle dystonic behaviors [34]. Thus, the use of both mouse models allows us to deliberately silence excitatory olivocerebellar synapses while also providing us with an opportunity to query varying severities of cerebellar dysfunction.
In this work, we report that, despite their different dystonia-related motor severities, Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice display similarly impaired sleep physiology and circadian rhythms. Both mutants display highly disrupted sleep, spending greater time awake and in NREM sleep at the expense of REM sleep. Furthermore, we found that both the Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mutant mice display increased latency to reach REM, which is similar to what is observed in human patients with dystonia [23]. Intriguingly, only mice with overt dystonic motor behaviors (Ptf1aCre;Vglut2fx/fx) show differences in ECoG spectral power frequency, particularly in the latter half of the time spent asleep. We also found that circadian activity rhythms remain unchanged across all groups of mice, and that the circadian “master clock” remains ostensibly unaffected by our circuit manipulation. Our work demonstrates that aberrant cerebellar activity dually disrupts motor function and sleep, paving the way for improved future therapeutics that may be able to simultaneously address both motor and sleep dysfunction in the context of motor disease.
Methods
Animals
All mice used in this study were housed in a Level 3, AALAS-certified facility. All experiments and studies that involved mice were reviewed and approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine (BCM AN-5996). Dr Chris Wright (Vanderbilt University School of Medicine) kindly provided the Ptf1aCre mice. We purchased the Pdx1Cre (Pdx-Cre, #014647) and Vglut2floxed (Vglut2fx, #012898) mice from The Jackson Laboratory (Bar Harbor, ME, USA) and then maintained them in our colony using a standard breeding scheme. The conditional knock-out mice that resulted in dystonia were generated by crossing Ptf1aCre;Vglut2fx/fx heterozygote mice or Pdx1Cre;Vglut2fx/fx heterozygote mice with homozygote Vglut2fx/fx mice. Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice were considered experimental animals. A full description of the genotyping details (e.g., primer sequences and the use of a standard polymerase chain reaction) and phenotype for the Ptf1aCre;Vglut2fx/fx mouse was provided in White and Sillitoe, 2017 [4]. A full description of the genotype and the initial observations of the phenotype of the Pdx1Cre;Vglut2fx/fx mouse was provided in Lackey, 2022 [34]. All littermates lacking Cre upon genotyping were considered control mice. Ear punches were collected before weaning and used for genotyping and identification of the different alleles. For all experiments, we bred mice using standard timed pregnancies, noon on the day a vaginal plug was detected was considered embryonic day (E)0.5 and postnatal day (P)0 was defined as the day of birth. Mice of both sexes were used in all experiments.
Immunohistochemistry
Perfusion and tissue fixation were performed as previously described [35]. Briefly, mice were anesthetized by intraperitoneal injection with Avertin (2, 2, 2-Tribromoethanol, Sigma-Aldrich, St. Louis, MO, USA; catalog #T4). Cardiac perfusion was performed with 0.1 M phosphate-buffered saline (PBS; pH 7.4), then by 4% paraformaldehyde (4% PFA) diluted in PBS. For cryoembedding, brains were post-fixed at 4°C for 24–48 h in 4% PFA and then cryoprotected stepwise in sucrose solutions (15% and 30% diluted in PBS) and embedded in Tissue-Tek O.C.T. compound (Sakura Finetek, Torrance, CA, USA; catalog #4583). Tissue sections were cut on a cryostat at a thickness of 40 μm and individual free-floating sections were collected sequentially and immediately placed into PBS. Our procedures for immunohistochemistry on free-floating frozen cut tissue sections have been described extensively in previous work [36, 37]. After completing the staining steps, the tissue sections were placed on electrostatically coated glass slides and allowed to dry.
Rabbit polyclonal anti-CA VIII (CAR8, 1:500, Proteintech # 12391-1-AP) and rabbit polyclonal anti-IP3R1 (1:500, Invitrogen # PA1-901) were used to label Purkinje cells. Guinea pig polyclonal anti-VGLUT2 (1:500, Synaptic systems # 135 404) was used to label olivocerebellar climbing fibers and their terminals. We visualized immunoreactive complexes using anti-rabbit or anti-guinea pig secondary antibodies conjugated to Alexa-488 and -647 fluorophores (1:1000 for both, Invitrogen, Waltham, MA, USA).
Tissue preparation and processing for in situ hybridization
Mice were anaesthetized with isoflurane and brains were removed from the skull and immersed in OCT (optimal cutting temperature). Immersed brains were flash frozen by placing tissue molds onto dry ice. Sagittal sections (25 μm) were cut through the cerebellum and the slices placed onto electrostatically coated glass slides (Probe On Plus Fisher Brand; Fisher Scientific). The tissue was probed with Vglut2 (SLC17A6) or Vgat (SLC32A1) digoxigenin-labelled mRNA probes using an automated in situ hybridization procedure (Genepaint). All reagent incubations, washes and stains were automated and performed by the in situ hybridization robot. The signal was detected by colorimetric detection using BCPI/NBT reagents. After processing was completed, the slides were removed from the machine and then cover-slipped with permanent mounting medium (Entellan mounting media, Electron Microscopy Sciences, Hatfield, PA, USA) and left to dry before imaging.
Wheel-running behavior
Recordings were maintained in a ventilated, temperature-controlled, and light-tight room under either a 12:12 LD cycle or DD conditions. Mice were singly housed in wheel-running cages and allowed to entrain to the LD cycle for 2 weeks, before being released into DD conditions for 21 days, to assess endogenous circadian timekeeping ability. We assessed period length, activity onset, and average number of wheel revolutions per 5 min using ClockLab Analysis (Actimetrics).
ECoG/EMG sleep recordings
Mice were anesthetized with isoflurane and placed into a stereotaxic device, which continued to deliver isoflurane throughout surgery. Each mouse with implanted with a prefabricated ECoG/EMG headmount (Pinnacle Technology, Lawrence KS, #8201) with 0.10” EEG screws to secure headmounts to the skull (Pinnacle Technology, Lawrence KS, #8209). A midline incision was made, and the skull was exposed. The headmount was affixed to the skull using cyanoacrylate glue to hold in place while pilot holes for screws were made and screws were inserted. Screws were placed bilaterally over parietal cortex and frontal cortex. A small amount of silver epoxy (Pinnacle Technology, Lawrence KS, #8226) was applied to the screw-headmount connection. Platinum-iridium EMG wires on the prefabricated headmount were placed under the skin of the neck, resting directly on the trapezius muscles. The headmount was permanently affixed to the skull using “Cold-Cure” dental cement (A-M systems, #525000 and #526000). Mice were allowed to recover for 3–4 days before being fitted with a preamplifier (#8202) and tethered to the recording device (#8204 and #8206-HR). ECoG and EMG signals were sampled at 400 Hz with 0.5 Hz and 10 Hz high-pass filters respectively.
Mice were recorded in light and temperature-controlled rooms, for 8 h, at the same time of day for every mouse. The first hour of recording was considered the acclimation period and was therefore excluded from final analysis. Food and water were available ad libitum throughout the recording day.
Sleep scoring and analysis of sleep data
Sleep was automatically scored offline via SPINDLE [38]. For spectral frequency analysis of ECoG and EMG activity, raw files were also pre-processed in MATLAB (MathWorks) using the free toolkit EEGLAB (UC San Diego). Scored files were downloaded from SPINDLE as a.csv and statistical analysis was performed in R v4.1.2. Only ECoG spectral power from frontal cortex is discussed in depth, as the spectral power from parietal cortex was the same between all groups for all frequency bands: Delta: one-way ANOVA, F = 0.031, p = 0.97, Theta: one-way ANOVA, F = 0.663, p = 0.524, Alpha: one-way ANOVA, F = 0.327, p = 0.724, Beta: one-way ANOVA, F = 0.079, p = 0.924, Gamma: one-way ANOVA, F = 0.483, p = 0.622.
Data analysis and statistics
Data are presented as mean ± SEM and analyzed as a one-way ANOVA followed by Tukey’s Honest Significant Difference test for post-hoc comparisons or a repeated measures two-way ANOVA with Bonferroni correction for multiple comparisons. p < 0.05 was considered as statistically significant. All statistical analyses were performed using R v4.1.2.
Results
Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice display overlapping cerebellar circuit deficits, but only the Ptf1aCre;Vglut2fx/fx mice show overt dystonic symptoms
We have previously demonstrated that silencing glutamatergic olivocerebellar synapses can induce severe dystonic motor phenotypes [4]. To elucidate the relative contributions of cerebellar versus motor dysfunction on sleep impairments, we additionally leveraged a previously generated mouse model of cerebellar dysfunction lacking overt motor dysfunction: the Pdx1Cre;Vglut2fx/fx mouse [34] (Supplementary Video S1). Both the Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mouse models utilize the Cre/lox-p system to drive the deletion of Vglut2, but under different promoters (Figure 1A). A detailed characterization of the Ptf1aCre;Vglut2fx/fx mice and their resulting dystonia were previously described [4], whereas the behavior and circuit basis of the Pdx1Cre;Vglut2fx/fx mice will be described extensively in an independent study (Lackey et al., 2023 in preparation). While both models result in the loss of VGLUT2 protein after genetically targeting glutamatergic olivocerebellar synapses in Purkinje cells (Figures 1B, C), the differential expression patterns of Ptf1a (in climbing fiber neurons) and Pdx1 (in climbing fiber and mossy fiber neurons) yield differential synapse silencing resulting in different motor phenotypes (Figure 1D; Supplementary Figure S1). Compared to wildtype littermate controls (Figure 1E), the Ptf1aCre;Vglut2fx/fx mice display overt dystonic motor phenotypes and dystonic behaviors (Figure 1F), while the Pdx1Cre;Vglut2fx/fx mice do not display overt dystonic motor phenotypes such as spontaneous twisting postures and hyperextension of the back, limbs, or digits (Figure 1G). To better understand the alterations in motor phenotypes in both mouse models, we implanted mice with cortical (ECoG) and muscular (EMG) electrodes for in vivo monitoring. We calculated the overall EMG power in the 0–30 Hz frequency range, which has been previously used to quantitatively diagnose dystonia in human patients [39] (representative EMG traces per genotype; Figure 1H). As predicted, the overall EMG power was significantly elevated in the Ptf1aCre;Vglut2fx/fx mice as compared to the control and Pdx1Cre;Vglut2fx/fx mice (Figures 1H, I). The EMG activity reflects prolonged over-contractions, which is a key phenotype observed in human patients with generalized and focal dystonia. Additionally, we found that this elevation of cervical EMG activity was maintained during all states, including both REM and NREM sleep (Supplementary Figures S2B–E). These findings support the idea that Ptf1aCre;Vglut2fx/fx mice display elevated muscle activity due to cerebellar dysfunction, while Pdx1Cre;Vglut2fx/fx mice do not. These results further suggest that cerebellar circuit manipulations can occur without causing overt and severe motor dysfunctions and furthermore establishes the two mouse models for use in subsequent experiments in this study.
FIGURE 1. Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice display differential dystonic motor phenotypes. (A) Using either the Ptf1aCre or Pdx1Cre genetic driver lines, exon 2 of Vglut2 was selectively removed and as a result VGLUT2 expression was deleted with spatial specificity. (B) Schematic illustration demonstrating the result of the Vglut2 deletion and the subsequent synaptic silencing in the affected cells. (C) Immunohistochemical staining of the cerebellar cortex, showing Purkinje cells (blue) and VGLUT2-positive climbing fibers from the inferior olive (gold). Abbreviations: ML, molecular layer; PCL, Purkinje cell layer. (D) Schematic demonstrating the end-result of the Vglut2 deletion in the Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice. Ptf1aCre;Vglut2fx/fx mice have widespread silencing of olivocerebellar glutamatergic synapses, while Pdx1Cre;Vglut2fx/fx mice have comparatively more restricted silencing of a subset of olivocerebellar synapses. Abbreviations: GC, granule cell; MF, mossy fiber; PC, Purkinje cell, CF, climbing fiber; CN, cerebellar nuclei; IO, inferior olive. (E) Video still from a control mouse with no atypical function. (F) Video still demonstrating dystonic postures in a Ptf1aCre;Vglut2fx/fx mouse, specifically showing the hindlimb hyperextension and Straub tail (noted by red and blue arrows). (G) Video still from a Pdx1Cre;Vglut2fx/fx mouse demonstrating the absence of overt dystonic motor dysfunction. (H) Raw EMG waveforms of trapezius muscle activity for a 3 s period. Control (grey), Ptf1aCre;Vglut2fx/fx (gold), and Pdx1Cre;Vglut2fx/fx (purple) mice. (I) Quantification of the overall EMG activity (0–30 Hz) for all mice used in the study. Points on I represent individual mice, n = 10 per group. Source data and specific p-values for I are available in Supplementary Table S1.
Circadian activity is unchanged in Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mutant mice
Wheel-running activity is commonly used in rodents as a proxy for measuring daily activity patterns [40]. Previous work has used wheel-running to understand circadian activity in other mouse models of movement disorders (for example, mild ataxia) [41]. Therefore, we sought to determine the extent of circadian activity disruption in Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mutant mice. Mice were singly housed with ad libitum access to food, water, and a running wheel in their home cage (Figure 2A). Wheel revolutions were automatically monitored throughout the recording period that lasted 35 days (14 days baseline (LD; light-dark), 21 days constant condition (DD; dark-dark periods; Figure 2B)). The collected data were analyzed and plotted as actograms for ease of viewing; each row represents a day and black tick marks represent revolutions of the running wheel, indicative of locomotor activity. Data is double plotted (as convention), such that 48 h of activity are plotted on the same line, to better visualize changes in activity patterns [40]. We predicted that differences in circadian activity patterns in our mutant mice would arise either from motor dysfunction or our cerebellar circuit manipulation. Given that Pdx1Cre;Vglut2fx/fx mice do not display severe dystonic motor behaviors, and the extent of their olivocerebellar manipulation is restricted relative to Ptf1aCre;Vglut2fx/fx mice, we predicted that their circadian activity profiles would remain unchanged relative to littermate controls. As expected, we observed normal wheel-running behavior in Pdx1Cre;Vglut2fx/fx mice relative to littermate controls (Figures 2C, E). We also found that despite their overt motor dysfunction, Ptf1aCre;Vglut2fx/fx mice did voluntarily run on the wheel and maintain rhythmic behavior, though after a longer (8-days) acclimation period (Figure 2D). We observed significantly lower average activity counts for Ptf1aCre;Vglut2fx/fx mice with overt motor dysfunction during both LD and DD paradigms (Figures 2F, G). Nevertheless, both Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice displayed characteristic nocturnal behavior even during the DD phase, similar to controls (Figures 2C–E). We also assessed endogenous circadian period length (tau), a measure of the period of a circadian rhythm. The tau length refers to the length of time it takes for the rhythm to complete one cycle [40]. At the end of the DD paradigm, all mice displayed an average tau of ∼23.7 h (Figure 2H). This slight deviation from 24 h is expected, as endogenous tau length in mice is slightly less than 24 h [40]. In addition, we also found that the “siesta” period—a brief bout of sleep during the active period [42] — in Ptf1aCre;Vglut2fx/fx mice is significantly longer by 7–10 min (Figure 2I). However, this increase may be a result of the low background activity for Ptf1aCre;Vglut2fx/fx mice. To validate that our genetic manipulation of Vglut2 did not significantly alter the major sleep center of the brain, we assessed Vglut2 mRNA expression in control Ptf1aCre and Pdx1Cre mice (without floxed alleles of Vglut2) using in situ hybridization. We found a lack of Vglut2 expression in the suprachiasmatic nucleus (SCN) “master clock.” This was anticipated since the SCN is a heavily GABAergic region [43] (Vgat-expressing, Supplementary Figure S3). These results suggest that in the Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice, circadian rhythms remain largely unchanged despite cerebellar and motor dysfunction.
FIGURE 2. Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice display normal circadian rhythmicity. (A) Schematic illustration of the wheel-running setup. (B) Timeline of wheel-running experiment. (C) Representative double-plotted actogram for a control mouse. Each row represents a day, black tick marks represent wheel-running activity (measured as revolutions of the running wheel). Black shaded regions represent “lights OFF,” unshaded regions represent “lights ON”. (D) Same as (C) but for a Pdx1Cre;Vglut2fx/fx mouse. (E) Same as (C) but for a Ptf1aCre;Vglut2fx/fx mouse. (F) Quantification of average activity counts per 5min for all mice, only during the LD paradigm. (G) Same as (F) but only quantifying activity during the DD paradigm. (H) Quantification of circadian period (tau) for all mice, during the DD paradigm. (I) Quantification of “siesta” bout length for all mice throughout the 35 days recording period. Points on F–I represent individual mice, n = 9 mice per group. The source data and specific p-values for F–I are available in Supplementary Table S2.
Cerebellar dysfunction disrupts sleep stages independently of the dystonic phenotype
The relationship between sleep and motor function is particularly relevant in dystonia, as reports suggest that motor symptoms are easier to manage after a good night’s sleep, and earlier in the morning, shortly after waking up [44]. Therefore, a major goal was to determine the overall sleep quality in Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice. We implanted Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice with ECoG/EMG electrodes that were made out of silver wire and recorded signals continuously for 8 h during the light phase (Figures 3A–C). Raw ECoG/EMG waveforms show that both Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice display characteristic spectral activity which defines wake, NREM, and REM sleep (Figure 3D). We also note that high-amplitude spikes in the EMG activity were observed in Ptf1aCre;Vglut2fx/fx mice during brief periods of wake, indicative of motor dysfunction, while no such phenomenon was observed in the Pdx1Cre;Vglut2fx/fx mice (Figure 3D). We then assessed the total time spent awake, in NREM sleep, and in REM sleep. While sleep cycles in mice are shorter than in humans, they do follow the similar pattern of wake, followed by NREM, and then REM sleep (Figure 3E). Representative hypnograms of 1 h of total recording time showed that both the Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice displayed disrupted sleep. The periods of wake were more frequent and last longer compared to the littermate controls (Figure 3F). We found that both Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice spent more time awake and in NREM at the expense of decreased REM sleep (Figures 3G–I). These results suggest that, although motor dysfunction may occur in brief periods of spontaneous wakefulness (Ptf1aCre;Vglut2fx/fx), cerebellar dysfunction alone may be sufficient to alter sleep activity independent from gross motor dysfunction (Pdx1Cre;Vglut2fx/fx).
FIGURE 3. Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice display disrupted sleep patterns. (A) Schematic illustration of the experimental timeline. (B) Schematic illustration of a mouse brain showing the placement of the ECoG/EMG headmount. An image of the headmount and mounting screws is also shown in the bottom left. (C) Video still from a sample sleep recording showing the experimental setup while a mouse is being recorded. (D) Raw waveforms of EMG activity (top trace for each sample) and ECoG activity (bottom two traces for each sample) for representative mice from each group. Each example is 60-seconds in length. Sleep stage, as determined by SPINDLE (see Methods), is noted under each example. Dotted red lines are added to help distinguish each sleep/wake state. (E) Schematic showing sleep stages and their organization for a mouse. (F) Hypnograms for a single representative mouse from each group, for the same 1 h period, ZT7-ZT8, where ZT0 = lights ON, ZT1 = 1 h after lights ON, etc. Periods of wake are highlighted in red. (G) Quantification of total time spent awake for all mice in each group. (H) Quantification of the total time spent in REM for all mice in each group. (I) Quantification of the total time spent in NREM for all mice in each group. Points on G–I represent individual mice, n = 10 mice per group. The source data and specific p-values for G–I are shown in Supplementary Table S3.
Disrupted sleep patterns occur independent of overt dystonic motor dysfunction when comparing Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx models of dystonia
We observed that cerebellar dysfunction was sufficient to disrupt sleep stages in Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice, mouse models with and without overt dystonic motor phenotypes, respectively. However, the fluctuations in the frequency of sleep stages or length of sleep states, both of which could be driving the observed differences in sleep versus awake time, remained unclear (Figure 4A). Therefore, to further understand the fragility of sleep stages, and the disruption of each stage, we calculated both the total number of sleep-stage bouts along with the average length of bouts for wake, NREM, and REM. We note that these calculations were performed after the onset of sleep, which was determined using a similar approach to previous work [45] (Figure 4B). We found that the total number of wake bouts was not different between Ptf1aCre;Vglut2fx/fx, Pdx1Cre;Vglut2fx/fx, and the littermate controls (Figure 4C). However, for both Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mutant mice, the awake bouts were significantly longer than in controls, by an average of ∼67 min (Figure 4D). To examine the disruptions in sleep stages after sleep onset, we calculated the total number of REM and NREM bouts. We found that both the Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice displayed an increase in the overall number of NREM bouts coupled with fewer REM bouts (Figures 4E, G), while the average length of both REM and NREM bouts remained the same between all groups (Figures 4F, H). Previous work in human patients with cervical dystonia suggests that dystonic patients display an increased latency to sleep, with a particular effect on the REM stage of sleep [23]. We hypothesized that these phenotypes may be recapitulated in the Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice. Therefore, we calculated the latency to reach REM and NREM sleep, as this could further indicate whether sleep dysfunction is primarily related to falling asleep versus staying asleep (or both). While both groups of mutant mice displayed a normal latency to reach NREM sleep (Figure 4J), latency to reach REM sleep was significantly elevated in both groups by an average of 47 min (Figure 4I). Together, these experiments highlight the specific deficits of sleep architecture that have been disordered in the Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mutant mice, and that the same deficits occur in both groups independently of how severe and constant the motor phenotype may be.
FIGURE 4. Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mutant mice display equivalent impairments in sleep. (A) Schematic with hypnogram examples of how possible forms of sleep disruption may appear. (B) Schematic showing sleep recording timeline and how sleep onset, NREM latency, and REM latency were defined and calculated, similar to Hunsley & Palmiter, 2004 [45]. (C) Quantification of the total number of wake bouts. (D) Quantification of the average length of wake bouts. (E) Quantification for the number of REM bouts after sleep onset. (F) Quantification for the average length of REM bouts. (G) Quantification for the number of NREM bouts after sleep onset. (H) Quantification of the average length of NREM bouts. (I) Quantification of the latency to REM sleep. (J) Quantification of the latency to NREM sleep. Points on C–J represent individual mice, n = 10 mice per group. The source data and specific p-values for C–J are available in Supplementary Table S4.
Changes in delta, beta, and gamma spectral power may underlie sleep state impairments in Ptf1aCre;Vglut2fx/fx but not Pdx1Cre;Vglut2fx/fx mice
Arousal states are defined, in part, by spectral frequency oscillations that occur across specific frequency bands, ranging from 0.5 to >100 Hz (Figure 5A). Accordingly, changes in sleep stages are marked by changes in delta (0.5Hz–4 Hz in mice) or theta (5Hz–8 Hz in mice) power, indicating both an increase or a decrease in sleep quality [46, 47]. Therefore, changes in spectral power can give some insight as to how sleep/wake dynamics are being interrupted at the neuronal level. As dystonia is a heterogenous motor disorder [1], and our two mouse models show differing severity in dystonic motor symptoms overall, we predicted that between the models we would see specific differences in ECoG spectral activity in sleep-dependent frequency bands. Such analysis may also provide insight into the potential mechanisms of sleep dysfunction, given that different frequency bands can be used to report on changes in overall brain connectivity [48]. We therefore sought to determine whether the Pdx1Cre;Vglut2fx/fx and the Ptf1aCre;Vglut2fx/fx mice displayed measurable differences in spectral power across frequency bands of interest (Figure 5B), relative to controls. We implanted mice with two cortical (ECoG) electrodes to detect changes in oscillation power spectral frequency at various sleep stages. We calculated overall average spectral power frequency from two independent ECoG electrodes placed over the parietal cortex and the frontal cortex, to measure delta (0.5–4 Hz), theta (5–8 Hz), alpha (8–13 Hz), beta (13–30 Hz), and gamma (35–44 Hz) frequency bands. Ptf1aCre;Vglut2fx/fx, but not the Pdx1Cre;Vglut2fx/fx mice, displayed differential spectral power frequencies in the frontal cortex for delta and beta frequency bands (Figures 5C, I). Specifically, delta power was significantly increased relative to the controls, while beta power was decreased. As delta power can be an effective indicator of NREM sleep, this observed increase may reflect the overall increased time spent in NREM sleep that the Ptf1aCre;Vglut2fx/fx mice display. We also note that although gamma power was decreased in Ptf1aCre;Vglut2fx/fx mice, the change did not meet the threshold for significance (Figure 5K). Overall, theta and alpha power were unchanged from controls for Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice (Figures 5E, G).
FIGURE 5. Ptf1aCre;Vglut2fx/fx mice show differences in spectral frequency oscillations that define arousal states. (A) 2.5 s samples of raw ECoG waveforms for awake, REM, and NREM from a control mouse. (B) 1 s samples of raw ECoG waveforms for frequency bands of interest, from a control mouse. (C) Quantification of delta power (0–4 Hz). Average power across the entire recording period. (D) Quantification of the changing delta power across the recording period. (E) Quantification of theta power (5–8 Hz). Average power across the entire recording period. (F) Quantification of the changing theta power across the recording period. (G) Quantification of alpha power (8–13 Hz). Average power across the entire recording period. (H) Quantification of the changing alpha power across the recording period. (I) Quantification of beta power (13–30 Hz). Average power across the entire recording period. (J) Quantification of the changing beta power across the recording period. (K) Quantification of gamma power (35–44 Hz). Average power across the entire recording period. (L) Quantification of the changing gamma power across the recording period. Points on C–L represent individual mice, n = 10 mice per group. The source data and specific p-values for C–L are available in Supplementary Table S5.
Sleep, and by extension the spectral oscillations defining sleep, are known to possess some intrinsic rhythmicity. Therefore, we also sought to determine whether the observed changes in spectral frequency power displayed temporal properties. To do this, we divided each animal’s sleep recording into 3 distinct periods. After performing spectral frequency analysis, we found that Ptf1aCre;Vglut2fx/fx mice continue to display increased delta and decreased beta power (Figures 5D, J). Interestingly, for both frequency bands, spectral power was only different during mid (ZT6-8) and late (ZT8-10) recording periods. For Gamma power, a significant decrease was only observed during the mid-recording period for both Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice (Figure 5L). As we observed with overall power, neither theta nor alpha showed differences when we calculated changing power over time (Figures 5F, H). These data demonstrate that measurable spectral frequency changes accompany sleep impairments in dystonia, but predominantly in Ptf1aCre;Vglut2fx/fx mice that experience overt motor dysfunction. The data indicate the possibility that while sleep impairments arise from cerebellar dysfunction in dystonia, the overt motor defects, which can arise in parallel, can also influence specific aspects of sleep physiology in the disease.
Discussion
We genetically dissected the interaction between sleep impairments and cerebellar-initiated motor impairments in two mouse models of dystonia. Altogether, the results from this work provide insight into the unique sleep, ECoG, and EMG disturbances observed in our mouse models of cerebellar circuit dysfunction (Figure 6A). We found that sleep impairments, a common nonmotor symptom in human dystonia, occur in Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mouse models of cerebellar miswiring, with and without severe dystonia-related motor dysfunctions. We show that both groups of mutant mice display an increase in the length of wake bouts, increased NREM and more frequent NREM bouts, and decreased REM and less frequent REM bouts (Figure 6A). While existing studies on sleep quality in dystonia patients is limited, our results are striking in that they reflect patterns of sleep deficits observed in dystonia patients [23–25]. We also highlight our finding that motor activity in Ptf1aCre;Vglut2fx/fx mice remains elevated in all stages of sleep, even during REM. This result is particularly intriguing. Existing studies are split, some suggesting that abnormal muscle activity in dystonic patients disappears during sleep [23] while other indicate that it might persist during sleep [24]. On the one hand, it is possible that our results indicate that dysfunction of the mechanisms involved in synaptic renormalization are affected in dystonia, which are believed to occur during sleep and mediate muscle recovery and atonia during sleep [32, 49, 50]. On the other hand, as a reconciling interpretation, the work we presented here could also suggest that cerebellar dysfunction, in the presence or absence of dystonic motor dysfunction, is sufficient to drive nonmotor impairments in sleep in mouse models of dystonia (Figure 6B). Existing knowledge suggests that the cerebellum and its circuit components (namely, the Purkinje cells and cerebellar nuclei neurons) are a key node in dystonia [4, 51]. Therefore, our results may point to the cerebellum as a central dystonia locus, which could help to anchor future studies on the development of therapies that can address motor and nonmotor (sleep) dysfunction in dystonia.
FIGURE 6. A model in which cerebellar dysfunction independently drives dystonic motor behavior and sleep impairments in Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice. (A) A summary of the main findings of this study, stratified for each mouse model. (B) A proposed model of the main finding of this study.
Evidence from case-control studies in patients with cervical dystonia suggests that human patients with dystonia exhibit distinct abnormalities in their circadian rhythms, including fatigue and excessive daytime sleepiness [25, 26, 52]. We sought to understand if the clinical symptoms of dystonia that are relevant to sleep were observed in our two mouse models that exhibit cerebellar dysfunction, with and without motor deficits. Our results show that both Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice display normal circadian timing of behavior (Figures 2C–E,H), suggesting that cerebellar dysfunction and motor deficits do not impact overall circadian behavior. Although these data are intriguing, given the substantial sleep impairments experienced by these mice, this finding is in line with work in mice with cerebellar ataxia, which also show normal circadian wheel-running behavior [41]. To make sure that our genetic manipulation in each model did not disrupt activity in the SCN master clock, we verified in our mice existing work, which states that the SCN is 95% GABAergic in its neuronal identity [43]. In accordance with our in situ hybridization results (Supplementary Figure S3), this may indicate that while the cerebellum is involved in the regulation of sleep, its role in circadian timekeeping is limited, at least in the current context. Indeed, while numerous projections exist between the cerebellum and the major circadian centers of the brain, including the hypothalamus, locus coeruleus, and pedunculopontine nucleus, direct projections between the cerebellum and the SCN master clock are lacking [53, 54]. It is possible then that cerebellar access to circadian processes is tightly regulated and restricted to sleep rather than overall activity rhythms. In this case, the fatigue and excessive daytime sleepiness experienced by patients with dystonia may be attributed to lack of sleep rather than aberrant circadian timekeeping.
While dystonia is commonly considered a network disorder in humans [1], our genetic manipulation attempts to recreate the circuit-wide defects through a mechanism that initiates the dystonia by precisely blocking glutamatergic signaling in the cerebellum. Although both Pdx1 and Ptf1a are expressed in several brain regions, including in the hypothalamus, neither Pdx1 nor Ptf1a is expressed in the SCN, the circadian master clock of the brain [33, 55]. Furthermore, as discussed before, over 95% of the cells in the suprachiasmatic nucleus are GABAergic [43], which further suggests that our genetic manipulation does not extend to directly affect the master clock. Indeed, our analysis of Vglut2 mRNA expression showed that Vglut2 expression in the suprachiasmatic nucleus is sparse (Supplementary Figure S3). As suggested by existing work, these regions instead heavily express Vgat, indicative of using primarily GABAergic signaling. Therefore, it is possible that human dystonia patients do experience malfunctioning circadian rhythmicity, but our model is unable to capture this specific aspect of heterogeneity in dystonia network dysfunction.
While overall circadian rhythm patterns remained unchanged in our mutant mice, we did observe a difference in siesta time for Ptf1aCre;Vglut2fx/fx mice. The siesta period is a brief bout of sleep during the active period [42]; it represents an important output of the circadian systems’ sleep regulation process [42, 56]. Thus, it serves as an additional marker of typical circadian rhythmicity. We note that the siesta period in the Ptf1aCre;Vglut2fx/fx mice does appear more pronounced and is significantly longer by 7–9 min (Figure 2I). However, given the low overall activity profile of the Ptf1aCre;Vglut2fx/fx mice, it is difficult to determine whether this increase in siesta time is circadian in origin, or if it arises as a result of the decreased overall activity, making the accurate calculation of siesta onset/offset difficult. Recent work does suggest that daily timing of the siesta is under control of the SCN [57], which we have determined to be spared from our genetic manipulation. Together, these data further support the finding that circadian rhythmicity is largely unaffected in Ptf1aCre;Vglut2fx/fx mice and also in the Pdx1Cre;Vglut2fx/fx model of dystonia.
Human studies suggest that alterations in sleep efficiency and sleep latency are prevalent in dystonia patients [19, 23, 24, 26, 52, 53]. We found that changes in sleep/wake dynamics are of particular interest, as they begin to explain the specific ways in which sleep deficits arise in the disease. Our results further suggest that REM disruption may be one of the primary sleep deficits encountered by our mouse models. We found not only that our mutants spend less time in REM, but that this impairment is complemented by an increase in both wake and NREM sleep (Figures 3G–I). Though mice sleep in bouts of 120–180 s per full sleep cycle [58] and not in long consolidated bouts like humans, they do follow similar sleep stage patterns (Figure 3E). Despite REM representing the lightest sleep stage, it is typically preceded by NREM sleep [59]. Therefore, the increase in NREM sleep combined with decrease in REM sleep suggests that the sleep deficits in our mice specifically result from involuntary waking during NREM sleep. This is further evidenced by our EMG results for the Ptf1aCre;Vglut2fx/fx mice, which display elevated cervical EMG power in all sleep states (Supplementary Figure S1). As mice must pass through NREM again before entering REM as they start a new sleep cycle, this prolongs the time spent in NREM while decreasing the time spent in REM. Further work needs to be conducted in order to connect our findings in mice to human patients with dystonia, as an equivalent result in humans could potentially explain the reported symptoms of daytime fatigue. Even if the total sleep time is similar between dystonic and non-dystonic patients, the quality of sleep is still being affected, as proportions of NREM versus REM during the sleeping phase are equally as important as overall time spent asleep versus awake [59].
Given the cerebellums’ known projections to/from a variety of cortical regions involved not only in sleep regulation, but also regulation of specific sleep stages (NREM and REM) [53, 54, 60], it was not unsurprising to find that sleep-stage specific deficits exist in both Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice. Other groups have found that dystonia patients [23, 26] and mouse models of motor dysfunction [61] present with sleep-stage specific deficits. Our findings of increased average wake bout length (Figure 4D), increased number of NREM bouts (Figure 4G) and decreased number of REM bouts (Figure 4E) specifically highlight and further reinforce our main findings of impairments in overall sleep stage timing. These results highlight the existence of significant REM-related sleep deficits. This is further reflected in our results of increased latency to reach REM for both Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice (Figure 4I). For Ptf1aCre;Vglut2fx/fx mice, the motor dysfunction may partially explain this result. REM-related sleep impairments are typically accompanied by some form of motor dysfunction [24, 26, 61], as the canonical mechanisms of muscle atonia during REM are disrupted [62]. However, since our Pdx1Cre;Vglut2fx/fx mouse model does not display overt motor dysfunction, but still displays the same wake, NREM, and particularly REM-related deficits, motor dysfunction may not be the sole culprit for impaired sleep. In this case, cerebellar dysfunction may also be to blame. Indeed, the cerebellum itself and many regions receiving direct cerebellar innervation are known to be involved in sleep regulation or control sleep-dependent behaviors, particularly REM regulation [53]. The locus coeruleus regulates NREM/REM intensity [63] while sending and receiving dense projections to cerebellar Purkinje cells and the cerebellar nuclei [64–66]. The pedunculopontine nucleus is a known regulator of REM sleep [67] and also sends/receives inputs between cerebellum and the basal ganglia [68]. Therefore, it is possible that the cerebellar malfunctions in the Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice directly and indirectly influence REM latency through intermediary regions such as the pedunculopontine nucleus or the locus coeruleus, or even other regions, all of which play a role in the regulation of REM sleep and receive/send direct innervation from the cerebellum [54, 60, 63]. The circuit pathways mediating the direct versus indirect effects on sleep were not resolved in the current work. Ultimately, the impaired sleep dynamics further reinforces our results, which suggest that Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice experience interrupted sleep cycles, cutting REM sleep short or missing it entirely and re-starting subsequent sleep cycles from NREM sleep.
Our ECoG spectral activity results are of particular interest from a mechanistic view, as they may not only explain the factors underlying sleep deficits in Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice but may also serve as additional “biomarkers” that differentiate each group based on their degree of cerebellar dysfunction. For instance, we observed an increase in delta power for Ptf1aCre;Vglut2fx/fx but not Pdx1Cre;Vglut2fx/fx mice, which occurs predominantly in the latter stages of recording (Figures 5C, D). The increase for Ptf1aCre;Vglut2fx/fx is in agreement with recent work suggesting that higher delta power is associated with arousal and sleep impairment, particularly in the context of obstructive sleep apnea which involves both motor dysfunction and cerebellar dysfunction [69]. However, as delta power in Pdx1Cre;Vglut2fx/fx is also elevated relative to control mice and is not significantly different from Ptf1aCre;Vglut2fx/fx, there stands the possibility that the lack of significance stems from the “intermediate” phenotype of Pdx1Cre;Vglut2fx/fx mice. We have shown that Pdx1Cre;Vglut2fx/fx mice lack overt motor dysfunction (Figures 1H, I; Supplementary Figure S2, Supplementary Video S1), and that the extent of Vglut2 deletion in the cerebellar cortex, at least with respect to the climbing fibers, is less extensive relative to the Ptf1aCre;Vglut2fx/fx mice (Supplementary Figure S1). Therefore, if we consider each mutant group as a model for different cerebellar/motor disorders of varying intensity, we expect to see such differences in spectral power despite similar sleep deficits. In this case, spectral differences may represent “biomarkers” of disease severity. It is known that changes in delta power can differ across individuals with different diseases even if all individuals display poor sleep [47]; it is possible then that Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice, even with an overlap in the genetic manipulations, indeed represent different manifestations of dystonic motor disease. Ultimately, this is evident with the difference in observed dystonic motor phenotypes between the two groups. It should be noted though, the measurement of sleep-related spectral difference between the Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice could still intersect with the induced alterations in the motor program, as movement patterns are known to impact ECoG spectral activity [70].
Additional patterns of significantly different spectral power for Ptf1aCre;Vglut2fx/fx but not Pdx1Cre;Vglut2fx/fx mice are seen for beta power, indicative of alert wakefulness (Figures 5I, J). While beta power is typically increased in patients with primary insomnia, previous work has shown that decreased beta activity is also associated with poor sleep quality, particularly in patients with obstructive sleep apneas [69]. The relationship between the cerebellum and breathing is well-established and may provide a fruitful avenue for further research in the context of dystonia. The cerebellum is known to be involved in both the rhythmicity of breathing and in regulating air hunger [71]; both mechanisms are known to play a role in obstructive sleep apneas [19, 72]. It is possible that Ptf1aCre;Vglut2fx/fx mice, with overt motor dysfunction, have some degree of sleep apnea behavior, which could contribute to their observed sleep impairment. Interestingly, cortical gamma power was only significantly changed during the middle of the recording period, for both the Pdx1Cre;Vglut2fx/fx and the Ptf1aCre;Vglut2fx/fx mutant mice (Figure 5L). While gamma oscillations are typically associated with working memory and attention, human and mouse EEG/ECoG studies have found that gamma oscillations occur spontaneously during REM and NREM sleep [73, 74]. This may explain why the overall gamma power is not significantly lower for either the Pdx1Cre;Vglut2fx/fx or Ptf1aCre;Vglut2fx/fx mice, yet it does reach the threshold for significance during “mid-recording”. Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice exhibit an increase in NREM and a decrease in REM sleep, and gamma oscillations spontaneously occur during both stages; changes in gamma activity may be effectively “canceled out” due to the opposing NREM and REM dynamics. While these observed changes in spectral frequency oscillations uncover some of the potential mechanisms driving the observed changes in sleep in our Ptf1aCre;Vglut2fx/fx and Pdx1Cre;Vglut2fx/fx mice, we note that attributing sleep disruption to specific directional changes in any one frequency band is difficult. Both positive and negative changes in average power, in any frequency band, can be associated with various disease states, and notably with disordered sleep [46, 47]. Therefore, here, we highlight the presence of a change in spectral frequency power as an indicator of fractured sleep homeostasis in our mouse circuit models of dystonia, without differentiating the specific directionality of the change in spectral frequency power.
Our findings build upon existing evidence from both human patients and mouse models of motor disease demonstrating that sleep impairments are a common nonmotor symptom in dystonia. Previous work has been unable to distinguish between dystonia-dependent versus independent sleep dysfunction, particularly in the context of dystonic motor dysfunction. Importantly, our results suggest a model in which cerebellar dysfunction alone (Figure 6B), without overt dystonic motor phenotypes, can drive sleep deficits. This may be an indication of a broader set of network dysfunctions in dystonia, with the cerebellum located at the center of multiple disease symptoms.
Data availability statement
All data generated or analyzed in this study are included in the article and Supplementary Material.
Ethics statement
Animal experimentation: All animals were housed in an AALAS-certified facility that operates on a 14 h light cycle. Husbandry, housing, euthanasia, and experimental guidelines were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Baylor College of Medicine (protocol number: AN-5996).
Author contributions
Technical and conceptual ideas in this work were conceived by LS and RS. LS performed the experiments and LS and RS performed data analysis and data interpretation. LS and RS wrote and edited the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by Baylor College of Medicine (BCM), Texas Children’s Hospital, The Hamill Foundation, and the National Institutes of Neurological Disorders and Stroke (NINDS) R01NS100874, R01NS119301, and R01NS127435 to RS. Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number P50HD103555 for use of the Animal Behavior Core and the Cell and Tissue Pathogenesis Core (BCM IDDRC). Support was also provided by a Dystonia Medical Research Foundation (DMRF) grant to RS. Research reported in this publication was supported in part by the RNA In Situ Hybridization Core facility at Baylor College of Medicine, which is supported by a Shared Instrumentation grant from the NIH (S10OD016167) and the NIH IDDRC grant U54HD083092 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Author disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontierspartnerships.org/articles/10.3389/dyst.2023.11487/full#supplementary-material.
SUPPLEMENTARY FIGURE S1 | Deletion of VGLUT2 in the cerebellum is more widespread in the climbing fibers of the Ptf1aCre;Vglut2fx/fx mice than in the Pdx1Cre;Vglut2fx/fx mice. (A) Quantification of relative fluorescence units (normalized per area) for each group. (B) Fluorescence immunohistochemical stain of the cerebellar cortex for a control mouse. Purkinje cell bodies and axons are shown in blue (labeled with CAR8/IP3R1). Climbing fibers express VGLUT2 and are labeled in gold. Scale bars are 20um and indicated with white bars. The molecular layer (ML) and Purkinje cell layer (PCL) are labeled for orientation. (C) Same as (B) but for a Ptf1aCre;Vglut2fx/fx mouse. (D) Same as (B) but for a Pdx1Cre;Vglut2fx/fx mouse. Points on A represent individual sections (n = 4) from 3 mice per group. The source data and specific p-values for A are available in Supplementary Table S6.
SUPPLEMENTARY FIGURE S2 | Cervical EMG activity in Ptf1aCre;Vglut2fx/fx mice remains elevated in all states. (A) Schematic illustration of a mouse showing the musculature and relative placement of the EMG electrodes. (B) Raw EMG waveforms of trapezius activity (3-seconds) for REM and NREM sleep for mice of each group. (C) Quantification of changing EMG power for control mice. ZT0 = lights ON, ZT4 = 4-hr after lights on… etc. (D) Same as (C) but for Ptf1aCre;Vglut2fx/fx mice. (E) Same as (C) but for Pdx1Cre;Vglut2fx/fx mice. Points on C–E represent individual mice, n = 10 mice per group. The source data and specific p-values for C–E are available in Supplementary Table S7.
SUPPLEMENTARY FIGURE S3 | The major circadian centers of the hypothalamus are comprised primarily of GABAergic inhibitory neurons. (A) Schematic illustration of a sagittal mouse brain highlighting several brain regions of interest that are related to circadian behavior. The hypothalamus is shown in blue, the suprachiasmatic nucleus (SCN) is in green, and the intermediate regions located between the SCN-cerebellum are shown in orange. (B) Images processed using in situ hybridization revealing Vglut2 mRNA expression on sagittal sections cut through the adult mouse brain. The regions of interest are outlined in white. (C) Same as (B) but for Vgat mRNA expression.
SUPPLEMENTARY VIDEO S1 | Differential motor phenotypes in Pdx1Cre;Vglut2fx/fx and Ptf1aCre;Vglut2fx/fx mice. A single video of the mutant mice showing the absence (Pdx1Cre;Vglut2fx/fx) and presence (Ptf1aCre;Vglut2fx/fx) of dystonic motor behaviors.
SUPPLEMENTARY TABLE S1 | Source data and statistics for Figure 1.
SUPPLEMENTARY TABLE S2 | Source data and statistics for Figure 2.
SUPPLEMENTARY TABLE S3 | Source data and statistics for Figure 3.
SUPPLEMENTARY TABLE S4 | Source data and statistics for Figure 4.
SUPPLEMENTARY TABLE S5 | Source data and statistics for Figure 5.
SUPPLEMENTARY TABLE S6 | Source data and statistics for Supplementary Figure S1.
SUPPLEMENTARY TABLE S7 | Source data and statistics for Supplementary Figure S2.
References
1. Corp, DT, Joutsa, J, Darby, RR, Delnooz, CCS, van de Warrenburg, BPC, Cooke, D, et al. Network localization of cervical dystonia based on causal brain lesions. Brain (2019) 142:1660–74. doi:10.1093/brain/awz112
2. Fremont, R, Tewari, A, Angueyra, C, and Khodakhah, K. A role for cerebellum in the hereditary dystonia DYT1. eLife (2017) 6:e22775. doi:10.7554/eLife.22775
3. Campbell, DB, North, JB, and Hess, EJ. Tottering mouse motor dysfunction is abolished on the purkinje cell degeneration (pcd) mutant background. Exp Neurol (1999) 160:268–78. doi:10.1006/exnr.1999.7171
4. White, JJ, and Sillitoe, RV. Genetic silencing of olivocerebellar synapses causes dystonia-like behaviour in mice. Nat Commun (2017) 8:14912. doi:10.1038/ncomms14912
5. van der Heijden, ME, Kizek, DJ, Perez, R, Ruff, EK, Ehrlich, ME, and Sillitoe, RV. Abnormal cerebellar function and tremor in a mouse model for non-manifesting partially penetrant dystonia type 6. J Physiol (2021) 599:2037–54. doi:10.1113/JP280978
6. Fremont, R, Tewari, A, and Khodakhah, K. Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of rapid onset dystonia-parkinsonism. Neurobiol Dis (2015) 82:200–12. doi:10.1016/j.nbd.2015.06.004
7. Washburn, S, Fremont, R, Moreno-Escobar, MC, Angueyra, C, and Khodakhah, K. Acute cerebellar knockdown of Sgce reproduces salient features of myoclonus-dystonia (DYT11) in mice. eLife (2019) 8:e52101. doi:10.7554/eLife.52101
8. Brown, EG, Bledsoe, IO, Luthra, NS, Miocinovic, S, Starr, PA, and Ostrem, JL. Cerebellar deep brain stimulation for acquired hemidystonia. Mov Disord Clin Pract (2020) 7:188–93. doi:10.1002/mdc3.12876
9. Horisawa, S, Kohara, K, Nonaka, T, Mochizuki, T, Kawamata, T, and Taira, T. Case report: deep cerebellar stimulation for tremor and dystonia. Front Neurol (2021) 12:642904. doi:10.3389/fneur.2021.642904
10. Popa, LS, Hewitt, AL, and Ebner, TJ. The cerebellum for jocks and nerds alike. Front Syst Neurosci (2014) 8:113. doi:10.3389/fnsys.2014.00113
11. Larry, N, Yarkoni, M, Lixenberg, A, and Joshua, M. Cerebellar climbing fibers encode expected reward size. eLife (2019) 8:e46870. doi:10.7554/eLife.46870
12. Carta, I, Chen, CH, Schott, AL, Dorizan, S, and Khodakhah, K. Cerebellar modulation of the reward circuitry and social behavior. Science (2019) 363:eaav0581. doi:10.1126/science.aav0581
13. Zhang, LB, Zhang, J, Sun, MJ, Chen, H, Yan, J, Luo, FL, et al. Neuronal activity in the cerebellum during the sleep-wakefulness transition in mice. Neurosci Bull (2020) 36:919–31. doi:10.1007/s12264-020-00511-9
14. Mano, N. Changes of simple and complex spike activity of cerebellar purkinje cells with sleep and waking. Science (1970) 170:1325–7. doi:10.1126/science.170.3964.1325
15. McCarley, RW, and Hobson, JA. Simple spike firing patterns of cat cerebellar purkinje cells in sleep and waking. Electroencephalogr Clin Neurophysiol (1972) 33:471–83. doi:10.1016/0013-4694(72)90211-8
16. Dang-Vu, TT, Schabus, M, Desseilles, M, Albouy, G, Boly, M, Darsaud, A, et al. Spontaneous neural activity during human slow wave sleep. Proc Natl Acad Sci (2008) 105:15160–5. doi:10.1073/pnas.0801819105
17. Cunchillos, JD, and De Andrés, I. Participation of the cerebellum in the regulation of the sleep-wakefulness cycle. Results in cerebellectomized cats. Electroencephalogr Clin Neurophysiol (1982) 53:549–58. doi:10.1016/0013-4694(82)90067-0
18. De Andrés, I, Garzón, M, and Reinoso-Suárez, F. Functional anatomy of non-REM sleep. Front Neurol (2011) 2:70. doi:10.3389/fneur.2011.00070
19. Song, B, and Zhu, JC. A narrative review of cerebellar malfunctions and sleep disturbances. Front Neurosci (2021) 15:590619. doi:10.3389/fnins.2021.590619
20. Bradnam, LV, Meiring, RM, Boyce, M, and McCambridge, A. Neurorehabilitation in dystonia: a holistic perspective. J Neural Transm (2021) 128:549–58. doi:10.1007/s00702-020-02265-0
21. Yang, J, Shao, N, Song, W, Wei, Q, Ou, R, Wu, Y, et al. Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm. Brain Behav (2016) 7:e00592. doi:10.1002/brb3.592
22. Duane, DD, and Bakken, EC. Additional clinical observations on psychiatric disorders in adult-onset focal dystonia: a case control study. Mov Disord (2011) 26:1572. author reply 1573. doi:10.1002/mds.23493
23. Antelmi, E, Ferri, R, Provini, F, Scaglione, CML, Mignani, F, Rundo, F, et al. Modulation of the muscle activity during sleep in cervical dystonia. Sleep (2017) 40:zsx088. doi:10.1093/sleep/zsx088
24. Smith, B. Lived experience with dystonia (2021). p. 633. Available from: https://dystoniasurveys.files.wordpress.com/2021/08/lived-experience-dystonia-patient-surveys-2020-2021.pdf (Accessed January 13, 2023).
25. Silvestri, R, De Domenico, P, Di Rosa, AE, Bramanti, P, Serra, S, and Di Perri, R. The effect of nocturnal physiological sleep on various movement disorders. Mov Disord (1990) 5:8–14. doi:10.1002/mds.870050104
26. Eichenseer, SR, Stebbins, GT, and Comella, CL. Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia. Parkinsonism Relat Disord (2014) 20:405–8. doi:10.1016/j.parkreldis.2014.01.004
27. Boudreau, P, Dumont, GA, and Boivin, DB. Circadian adaptation to night shift work influences sleep, performance, mood and the autonomic modulation of the heart. PloS One (2013) 8:e70813. doi:10.1371/journal.pone.0070813
28. Pimenta, AM, Kac, G, Souza, RRCE, Ferreira, LM, and Silqueira, SMF. Night-shift work and cardiovascular risk among employees of a public university. Rev Assoc Med Bras. (2012) 58:168–77. doi:10.1016/s2255-4823(12)70177-7
29. Al-Sharman, A, and Siengsukon, CF. Sleep enhances learning of a functional motor task in young adults. Phys Ther (2013) 93:1625–35. doi:10.2522/ptj.20120502
30. Walker, MP, Brakefield, T, Seidman, J, Morgan, A, Hobson, JA, and Stickgold, R. Sleep and the time course of motor skill learning. Learn Mem (2003) 10:275–84. doi:10.1101/lm.58503
31. De Zeeuw, CI, and Canto, CB. Sleep deprivation directly following eyeblink-conditioning impairs memory consolidation. Neurobiol Learn Mem (2020) 170:107165. doi:10.1016/j.nlm.2020.107165
32. Tononi, G, and Cirelli, C. Sleep and the price of plasticity: from synaptic and cellular homeostasis to memory consolidation and integration. Neuron (2014) 81:12–34. doi:10.1016/j.neuron.2013.12.025
33. Song, J, Xu, Y, Hu, X, Choi, B, and Tong, Q. Brain expression of Cre recombinase driven by pancreas-specific promoters. Genes. (2010) 48:628–34. doi:10.1002/dvg.20672
34. Lackey, E. Neural function of Cerebellar inputs in Dystonia-like behavior. Doctoral. Baylor College of Medicine (2022).
35. Zhou, J, Brown, AM, Lackey, EP, Arancillo, M, Lin, T, and Sillitoe, RV. Purkinje cell neurotransmission patterns cerebellar basket cells into zonal modules defined by distinct pinceau sizes. eLife (2020) 9:e55569. doi:10.7554/eLife.55569
36. Sillitoe, RV, Künzle, H, and Hawkes, R. Zebrin II compartmentation of the cerebellum in a basal insectivore, the madagascan hedgehog tenrec echinops telfairi. J Anat (2003) 203:283–96. doi:10.1046/j.1469-7580.2003.00216.x
37. White, JJ, and Sillitoe, RV. Postnatal development of cerebellar zones revealed by neurofilament heavy chain protein expression. Front Neuroanat (2013) 7:9. doi:10.3389/fnana.2013.00009
38. Miladinović, Đ, Muheim, C, Bauer, S, Spinnler, A, Noain, D, Bandarabadi, M, et al. Spindle: end-to-end learning from EEG/EMG to extrapolate animal sleep scoring across experimental settings, labs and species. PLOS Comput Biol (2019) 15:e1006968. doi:10.1371/journal.pcbi.1006968
39. Go, SA, Coleman-Wood, K, and Kaufman, KR. Frequency analysis of lower extremity electromyography signals for the quantitative diagnosis of dystonia. J Electromyogr Kinesiol (2014) 24:31–6. doi:10.1016/j.jelekin.2013.11.002
40. Eckel-Mahan, K, and Sassone-CorsiPhenotyping, P. Phenotyping circadian rhythms in mice. Curr Protoc Mouse Biol (2015) 5:271–81. doi:10.1002/9780470942390.mo140229
41. Mendoza, J, Pévet, P, Felder-Schmittbuhl, MP, Bailly, Y, and Challet, E. The cerebellum harbors a circadian oscillator involved in food anticipation. J Neurosci (2010) 30:1894–904. doi:10.1523/JNEUROSCI.5855-09.2010
42. Stowie, AC, and Glass, JD. Longitudinal study of changes in daily activity rhythms over the lifespan in individual male and female C57bl/6J mice. J Biol Rhythms (2015) 30:563–8. doi:10.1177/0748730415598023
43. Abrahamson, EE, and Moore, RY. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res (2001) 916:172–91. doi:10.1016/s0006-8993(01)02890-6
44. Caverzasio, S, Amato, N, Manconi, M, Prosperetti, C, Kaelin-Lang, A, Hutchison, WD, et al. Brain plasticity and sleep: implication for movement disorders. Neurosci Biobehav Rev (2018) 86:21–35. doi:10.1016/j.neubiorev.2017.12.009
45. Hunsley, MS, and Palmiter, RD. Altered sleep latency and arousal regulation in mice lacking norepinephrine. Pharmacol Biochem Behav (2004) 78:765–73. doi:10.1016/j.pbb.2004.05.008
46. Bjorness, TE, Booth, V, and Poe, GR. Hippocampal theta power pressure builds over non-REM sleep and dissipates within REM sleep episodes. Arch Ital Biol (2018) 156:112–26. doi:10.12871/00039829201833
47. Long, S, Ding, R, Wang, J, Yu, Y, Lu, J, and Yao, D. Sleep quality and electroencephalogram delta power. Front Neurosci (2021) 15:803507. doi:10.3389/fnins.2021.803507
48. Torres-Herraez, A, Watson, T, and Rondi-Reig, L. Delta oscillations coordinate intra-cerebellar and cerebello-hippocampal network dynamics during sleep. J Neurosci (2022) 42:2268–81. doi:10.1523/JNEUROSCI.1479-21.2021
49. Frank, MG. Sleep and synaptic plasticity in the developing and adult brain. Curr Top Behav Neurosci (2015) 25:123–49. doi:10.1007/7854_2014_305
50. Loschky, SS, Spano, GM, Marshall, W, Schroeder, A, Nemec, KM, Schiereck, SS, et al. Ultrastructural effects of sleep and wake on the parallel fiber synapses of the cerebellum. eLife (2022) 11:e84199. doi:10.7554/eLife.84199
51. Kim, JE, Chae, S, Kim, S, Jung, YJ, Kang, MG, Heo, WD, et al. Cerebellar 5HT-2A receptor mediates stress-induced onset of dystonia. Sci Adv (2021) 7:eabb5735. doi:10.1126/sciadv.abb5735
52. Smit, M, Kamphuis, ASJ, Bartels, AL, Han, V, Stewart, RE, Zijdewind, I, et al. Fatigue, sleep disturbances, and their influence on quality of life in cervical dystonia patients. Mov Disord Clin Pract (2017) 4:517–23. doi:10.1002/mdc3.12459
53. Salazar Leon, LE, and Sillitoe, RV. Potential interactions between cerebellar dysfunction and sleep disturbances in dystonia. Dystonia (2022) 1:10691. doi:10.3389/dyst.2022.10691
54. Van Dort, CJ, Zachs, DP, Kenny, JD, Zheng, S, Goldblum, RR, Gelwan, NA, et al. Optogenetic activation of cholinergic neurons in the PPT or LDT induces REM sleep. Proc Natl Acad Sci U S A (2015) 112:584–9. doi:10.1073/pnas.1423136112
55. Fujiyama, T, Miyashita, S, Tsuneoka, Y, Kanemaru, K, Kakizaki, M, Kanno, S, et al. Forebrain Ptf1a is required for sexual differentiation of the brain. Cell Rep (2018) 24:79–94. doi:10.1016/j.celrep.2018.06.010
56. Whitney, MS, Shemery, AM, Yaw, AM, Donovan, LJ, Glass, JD, and Deneris, ES. Adult brain serotonin deficiency causes hyperactivity, circadian disruption, and elimination of siestas. J Neurosci (2016) 36:9828–42. doi:10.1523/JNEUROSCI.1469-16.2016
57. Collins, B, Pierre-Ferrer, S, Muheim, C, Lukacsovich, D, Cai, Y, Spinnler, A, et al. Circadian VIPergic neurons of the suprachiasmatic nuclei sculpt the sleep-wake cycle. Neuron (2020) 108:486–99. doi:10.1016/j.neuron.2020.08.001
58. Adamantidis, AR, Zhang, F, Aravanis, AM, Deisseroth, K, and de Lecea, L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature (2007) 450:420–4. doi:10.1038/nature06310
59. Patel, AK, Reddy, V, Shumway, KR, and Araujo, JF. Physiology, sleep stages. In: StatPearls. Treasure Island, FL: StatPearls Publishing (2022).
60. Eban-Rothschild, A, Rothschild, G, Giardino, WJ, Jones, JR, and de Lecea, L. VTA dopaminergic neurons regulate ethologically relevant sleep–wake behaviors. Nat Neurosci (2016) 19:1356–66. doi:10.1038/nn.4377
61. Medeiros, DC, Lopes Aguiar, C, Moraes, MFD, and Fisone, G. Sleep disorders in rodent models of Parkinson’s disease. Front Pharmacol (2019) 10:1414. doi:10.3389/fphar.2019.01414
62. Lydic, R. The motor atonia of REM sleep: A critical topics forum. Introduction. Sleep (2008) 31:1471–2. doi:10.1093/sleep/31.11.1471
63. Swift, KM, Gross, BA, Frazer, MA, Bauer, DS, Clark, KJD, Vazey, EM, et al. Abnormal locus coeruleus sleep activity alters sleep signatures of memory consolidation and impairs place cell stability and spatial memory. Curr Biol (2018) 28:3599–609. doi:10.1016/j.cub.2018.09.054
64. Hoffer, BJ, Siggins, GR, Oliver, AP, and Bloom, FE. Activation of the pathway from locus coeruleus to rat cerebellar purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J Pharmacol Exp Ther (1973) 184:553–69.
65. Moises, HC, Waterhouse, BD, and Woodward, DJ. Locus coeruleus stimulation potentiates purkinje cell responses to afferent input: the climbing fiber system. Brain Res (1981) 222:43–64. doi:10.1016/0006-8993(81)90939-2
66. Schwarz, LA, Miyamichi, K, Gao, XJ, Beier, KT, Weissbourd, B, DeLoach, KE, et al. Viral-genetic tracing of the input-output organization of a central noradrenaline circuit. Nature (2015) 524:88–92. doi:10.1038/nature14600
67. Romigi, A, Placidi, F, Peppe, A, Pierantozzi, M, Izzi, F, Brusa, L, et al. Pedunculopontine nucleus stimulation influences REM sleep in Parkinson’s disease. Eur J Neurol (2008) 15:e64–5. doi:10.1111/j.1468-1331.2008.02167.x
68. French, IT, and Muthusamy, KA. A review of the pedunculopontine nucleus in Parkinson’s disease. Front Aging Neurosci (2018) 10:99. doi:10.3389/fnagi.2018.00099
69. Liu, S, Shen, J, Li, Y, Wang, J, Wang, J, Xu, J, et al. EEG power spectral analysis of abnormal cortical activations during REM/NREM sleep in obstructive sleep apnea. Front Neurol (2021) 12:643855. doi:10.3389/fneur.2021.643855
70. Mihajlovic, V, Patki, S, and Grundlehner, B. The impact of head movements on EEG and contact impedance: an adaptive filtering solution for motion artifact reduction. In: 2014 36th annual international conference of the IEEE engineering in medicine and biology society; 26-30 August 2014; Chicago, IL, USA (2014). p. 5064–7.
71. Liu, Y, Qi, S, Thomas, F, Correia, BL, Taylor, AP, Sillitoe, RV, et al. Loss of cerebellar function selectively affects intrinsic rhythmicity of eupneic breathing. Biol Open (2020) 9:bio048785. doi:10.1242/bio.048785
72. Canto, CB, Onuki, Y, Bruinsma, B, van der Werf, YD, and Zeeuw, CID. The sleeping cerebellum. Trends Neurosci (2017) 40:309–23. doi:10.1016/j.tins.2017.03.001
73. Brankack, J, Kukushka, VI, Vyssotski, AL, and Draguhn, A. EEG gamma frequency and sleep-wake scoring in mice: comparing two types of supervised classifiers. Brain Res (2010) 1322:59–71. doi:10.1016/j.brainres.2010.01.069
Keywords: dystonia, sleep, circadian rhythms, Purkinje cells, cerebellar nuclei
Citation: Salazar Leon LE and Sillitoe RV (2023) Disrupted sleep in dystonia depends on cerebellar function but not motor symptoms in mice. Dystonia 2:11487. doi: 10.3389/dyst.2023.11487
Received: 17 April 2023; Accepted: 11 August 2023;
Published: 24 August 2023.
Edited by:
Aasef Shaikh, Case Western Reserve University, United StatesCopyright © 2023 Salazar Leon and Sillitoe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Roy V. Sillitoe, c2lsbGl0b2VAYmNtLmVkdQ==